China’s uncertain biotechnology approval process influences the tools available in crop production. Biotechnology Innovation Organization President and CEO Michelle McMurray-Heath made that point while testifying before the Senate Finance Committee. “On average, it takes our companies seven years to just get approved in China and we estimate this has cost over $50 billion in a five-year period for U.S. farmers.” McMurray-Heath said agriculture needs a transparent, science-based process.
Subscribe to RRFN
Get a weekly digest from RRFN to stay up-to-date on all the latest news in agriculture.